Contract Service Directory

Renaissance Lakewood





Company Headquarters

1200 Paco Way
Lakewood, NJ 08701
United States

Company Description

Renaissance is your partner for nasal development and commercialization. Our state-of-the-art facility offers a full-service nasal spray lab, that can support all spray characterization method development and validation. Renaissance also offers analytical and micro lab services to facilitate development & release testing. With over 20 years of nasal expertise, Renaissance has become a leading CDMO for unit dose, bi-dose, and multidose nasal spray products in both sterile and non-sterile formats. Our other capabilities include development and manufacturing of sterile injectables.

Contract Service Directory

    Related Content


    • Bio News | Breaking News | Collaborations & Alliances | Industry News
      The Discovery Labs Signs Lease with UPenn

      The Discovery Labs Signs Lease with UPenn's Gene Therapy Program

      The University will use Discovery Labs’ campus for a portion of its research operations focused on the development of genetic medicines.
      Charles Sternberg, Assistant Editor 05.27.21

    • Innovative Development and Manufacturing Services

      For Global Cell and Gene Therapy Leadersin


    • Validation

    • Drug Development | Drug Discovery

    • Drug Development


    • Drug Development | Drug Discovery
      Recipharm Joins AMR Industry Alliance

      Recipharm Joins AMR Industry Alliance

      Aims to address growing concerns around antimicrobial resistance.
      11.14.19

    • Renaissance Lakewood

      Renaissance Lakewood's Eric Kaneps

      Renaissance's vice president of sales and marketing talked about the company's growth.
      Contract Pharma Staff



    • APIs
      Better Drug Manufacturing Strategies: Custom APIs

      Better Drug Manufacturing Strategies: Custom APIs

      Today’s biopharma companies are turning to their contractors for long-term collaboration and much higher levels of support.
      Tom Wilson, VP, Global Contract Manufacturing Leader, Pfizer CentreOne 10.15.19

    • Breaking News | Industry News
      VIDEO: Renaissance Lakewood

      VIDEO: Renaissance Lakewood's Eric Kaneps

      Renaissance's vice president of sales and marketing talked about the company's growth.
      10.02.19

    • Cytotoxics and High Potency Manufacturing
      API to ADC: A Journey Through High Potency

      API to ADC: A Journey Through High Potency

      This class of compounds represents a major advance in oncology research and treatment application.
      Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19


    • Ophthalmic Drug Delivery for Retinal Disorders

      Ophthalmic Drug Delivery for Retinal Disorders

      This whitepaper explores the development and manufacturing considerations associated with ophthalmic drug delivery, with a focus on retinal disorders.

    • Collaborations & Alliances | Drug Development
      Gilead and Nurix to Collaborate on Novel Therapies

      Gilead and Nurix to Collaborate on Novel Therapies

      Consisting of targeted protein degradation drugs for patients with cancer and other challenging diseases
      06.20.19

    • Drug Delivery
      Nasal Drug Delivery

      Nasal Drug Delivery

      A look at best practices for testing nasal drug delivery devices
      Maria Smith, senior manager & Charles Shaw, scientific advisor, Renaissance Lakewood LLC 01.25.19